Precision Antibody’s proprietary technology develops fully human antibodies in ~60 days

Precision Antibody’s proprietary technology develops fully human antibodies in ~60 days Precision Antibody has an exclusive license agreement with trans-chromosomic (Tc) mice carrying mini-chromosomes with megabase-sized human immunoglobulin (Ig) loci. Precision Antibody has developed a proprietary method to develop a strong immune response against therapeutic targets in three weeks, enabling fully human therapeutic antibody development […]